These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28771321)
41. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390 [TBL] [Abstract][Full Text] [Related]
42. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples. Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. Longworth M; Connor M; Banister SD; Kassiou M ACS Chem Neurosci; 2017 Aug; 8(8):1673-1680. PubMed ID: 28574245 [TBL] [Abstract][Full Text] [Related]
44. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort. Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050 [TBL] [Abstract][Full Text] [Related]
45. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry. Ford LT; Berg JD Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105 [TBL] [Abstract][Full Text] [Related]
46. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure. Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162 [TBL] [Abstract][Full Text] [Related]
47. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids. Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297 [TBL] [Abstract][Full Text] [Related]
48. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans? Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899 [TBL] [Abstract][Full Text] [Related]
49. EMCDDA framework and practical guidance for naming synthetic cannabinoids. Pulver B; Fischmann S; Gallegos A; Christie R Drug Test Anal; 2023 Mar; 15(3):255-276. PubMed ID: 36346325 [TBL] [Abstract][Full Text] [Related]
50. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Diao X; Huestis MA Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455 [TBL] [Abstract][Full Text] [Related]
51. The 2-alkyl-2 Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266 [TBL] [Abstract][Full Text] [Related]
52. Synthetic cannabinoids in hair - Pragmatic approach for method updates, compound prevalences and concentration ranges in authentic hair samples. Franz F; Jechle H; Angerer V; Pegoro M; Auwärter V; Neukamm MA Anal Chim Acta; 2018 May; 1006():61-73. PubMed ID: 30016265 [TBL] [Abstract][Full Text] [Related]
53. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Sobolevsky T; Prasolov I; Rodchenkov G Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760 [TBL] [Abstract][Full Text] [Related]
54. Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair. Kim J; Park Y; Park M; Kim E; Yang W; Baeck S; Lee S; Han S J Pharm Biomed Anal; 2015 Jan; 102():162-75. PubMed ID: 25282599 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds. Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526 [TBL] [Abstract][Full Text] [Related]
57. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples. Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642 [TBL] [Abstract][Full Text] [Related]
58. What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing. Bijlsma L; Gil-Solsona R; Hernández F; Sancho JV Anal Bioanal Chem; 2018 Aug; 410(21):5107-5112. PubMed ID: 29909458 [TBL] [Abstract][Full Text] [Related]
59. Molecularly imprinted polymer based quartz crystal microbalance sensor system for sensitive and label-free detection of synthetic cannabinoids in urine. Battal D; Akgönüllü S; Yalcin MS; Yavuz H; Denizli A Biosens Bioelectron; 2018 Jul; 111():10-17. PubMed ID: 29631158 [TBL] [Abstract][Full Text] [Related]
60. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens. Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]